Frizzled-2 activators belong to a specialized class of chemical compounds designed to modulate the activity of the Frizzled-2 receptor, a member of the Frizzled family of G protein-coupled receptors (GPCRs). Frizzled receptors are key components of the Wnt signaling pathway, a critical and evolutionarily conserved cellular signaling cascade that regulates various developmental processes, tissue homeostasis, and cell fate determination. Frizzled-2, in particular, is known for its role in mediating Wnt signaling events that orchestrate cell proliferation, differentiation, and tissue morphogenesis. Activation of Frizzled-2 by Wnt ligands triggers downstream signaling pathways that lead to the stabilization and nuclear translocation of beta-catenin, a transcriptional coactivator that controls the expression of target genes involved in crucial cellular functions.
Frizzled-2 activators are meticulously designed compounds engineered to interact with the Frizzled-2 receptor, influencing its activity and modulating downstream signaling events within the Wnt pathway. These compounds are fundamental tools for researchers investigating the molecular mechanisms of Wnt signaling and its impact on cellular processes. By manipulating Frizzled-2 activity, scientists can gain insights into the intricate regulatory networks that govern cell fate decisions, tissue development, and homeostasis. Frizzled-2 activators play a pivotal role in advancing our understanding of the fundamental biology of Wnt signaling, contributing to the broader field of cell and developmental biology, and providing insights into the intricate processes that drive cellular responses to extracellular cues.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3β, leading to stabilization of β-catenin, indirectly enhancing Wnt/Frizzled signaling. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $58.00 $188.00 $884.00 | 10 | |
GSK-3 Inhibitor IX promotes Wnt signaling by stabilizing β-catenin, indirectly affecting FZD2. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
GSK-3 Inhibitor XVI stabilizes β-catenin, thus promoting Wnt/Frizzled signaling. | ||||||
LGK 974 | 1243244-14-5 | sc-489380 sc-489380A | 5 mg 50 mg | $359.00 $1295.00 | 2 | |
PORCN inhibitor, affects Wnt ligand availability, indirectly influencing FZD2 activity. | ||||||
KY02111 | 1118807-13-8 | sc-397043 sc-397043A | 5 mg 25 mg | $79.00 $336.00 | ||
Promotes cardiomyocyte differentiation by inhibiting Wnt signaling, indirectly affecting FZD2. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
Inhibits Wnt signal transduction by promoting β-catenin degradation, indirectly influencing FZD2. | ||||||
Wnt Synergist, QS11 | 944328-88-5 | sc-222417 sc-222417A | 5 mg 25 mg | $141.00 $607.00 | ||
Activates Wnt/β-catenin signaling by inhibiting Gsk3β, affecting FZD2 function. | ||||||
β-Catenin/Tcf Inhibitor, FH535 | 108409-83-2 | sc-221398 sc-221398A | 10 mg 50 mg | $182.00 $374.00 | 7 | |
Dual inhibitor of Wnt/β-catenin and PPAR signaling, may influence FZD2 activity. | ||||||
Pyrvinium Pamoate | 3546-41-6 | sc-476920A sc-476920 | 250 mg 500 mg | $228.00 $422.00 | ||
Wnt signaling pathway activator, potentially affecting FZD2 activity. | ||||||